Actively Recruiting
A National Registry on Chinese Patients With Cystic Fibrosis
Led by Peking Union Medical College Hospital · Updated on 2022-03-21
200
Participants Needed
1
Research Sites
548 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. The main objectives of this study are to accurately evaluate the prevalence of CF, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.
CONDITIONS
Official Title
A National Registry on Chinese Patients With Cystic Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fulfilled WHO clinical diagnostic criteria for CF
- Was in a stable phase with no respiratory infections for nearly 4 weeks
- Subjects (or their guardians) signed informed consent
You will not qualify if you...
- Patients with other bronchiectasis who did not meet the inclusion criteria
- Those with severe cardiac or renal disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
X
Xinlun Tian, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here